Global Information
ȸ»ç¼Ò°³ | ¹®ÀÇ | ºñ±³¸®½ºÆ®

ü¿ÜÁø´Ü ÀǾàǰ ºñÁö´Ï½º Àü¸Á

In Vitro Diagnostics Business Outlook

¸®¼­Ä¡»ç Kalorama Information
¹ßÇàÁ¤º¸ ¿¬°£±¸µ¶ »óǰÄÚµå 1035040
ÆäÀÌÁö Á¤º¸ ¿µ¹®
US $ 2,200 £Ü 2,860,000 Single User License
US $ 4,995 £Ü 6,495,000 Team 5-User License
US $ 6,995 £Ü 9,096,000 Group 15-User License
US $ 11,995 £Ü 15,598,000 Department 50-User License
US $ 19,995 £Ü 26,001,000 Corporate 250-User License
US $ 30,000 £Ü 39,012,000 Enterprise - Unlimited User License


ü¿ÜÁø´Ü ÀǾàǰ ºñÁö´Ï½º Àü¸Á In Vitro Diagnostics Business Outlook
¹ßÇàÁ¤º¸ : ÆäÀÌÁö Á¤º¸ : ¿µ¹®

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹®¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ Ã¼¿ÜÁø´Ü ÀǾàǰ ºñÁö´Ï½º(In Vitro Diagnostics Business) ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä¿Í ÇÔ²² ½ÃÀå ±Ô¸ð, Ä«Å×°í¸®º° Ãֽе¿Çâ, Áö¿ªº° ½ÃÀå µ¿Çâ ¹× ½ÃÀå¿¡ Âü¿©ÇÏ´Â ±â¾÷ °³¿ä µîÀ» Á¦°øÇÕ´Ï´Ù.

»ùÇà ºä

º¸°í¼­ ³»¿ë
  • ü¿ÜÁø´Ü ÀǾàǰ(IVD) ½ÃÀå ºÎ¹®º° ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
  • ÀÓ»óÈ­ÇÐ, °¨¿°Áõ °Ë»ç, Á¾¾çÇÐ, Ç÷¾×ÇÐ, Ç÷¾×ÀºÇà, ÀÀ°í, POC(Point of Care) µî Áß¿äÇÑ °Ë»ç Ä«Å×°í¸®ÀÇ ÃֽŠÁ¤º¸
  • ¾÷°è ¿öÄ¡ - COVID-19¸¦ ºñ·ÔÇÑ °Ë»ç µ¿Çâ
  • M&A, À¯Åë, ÆÄÆ®³Ê½Ê ÃßÀû°ú ºÐ¼®
  • ½ÅÁ¦Ç° ¼Ò°³¿Í ±â¾÷ ¹ßÇ¥
  • ±â¾÷ °³¿ä¿Í ºÐ±âº° ½ÇÀû ¿ä¾à
  • Áö¿ªº° ½ÃÀå Á¤º¸
KSM 21.11.15

From Kalorama Information and Science and Medicine Group (publishers of Instrument Business Outlook) comes a new publication focusing on the business of clinical testing.

SAMPLE VIEW

‘In Vitro Diagnostics Business Outlook’ offers the following:

  • Market Sizing and Forecasting of IVD Market Segments in Every Issue
  • Clinical Chemistry, Infectious Disease Testing, Oncology, Hematology, Blood Banking, Coagulation, Point of Care-Updates on the Important Test Categories You Need to Know About
  • Industry Watch - Developments with COVID-19 and Other Testing
  • M&A, Distribution, Partnerships Tracked and Charted
  • New Product Introductions and Company Announcements
  • Company Profiling and Quarterly Results Summaries
  • Regional Market Coverage

With issues 2x a month, this newsletter dedicated to In Vitro Diagnostics is the best way to keep up in this rapidly-developing and well financed field.

Finding markets with higher growth than the average is critical.

Back to Top
ÀüÈ­ ¹®ÀÇ
F A Q